Autophagy: A Novel Pharmacological Target in Diabetic Retinopathy

Annagrazia Adornetto1, Carlo Gesualdo2, Maria Luisa Laganà1

  • 1Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

Insights

Autophagy dysfunction contributes to neurodegenerative diseases like diabetic retinopathy (DR). Targeting this cellular recycling process may offer new therapeutic strategies for DR, a leading cause of blindness.

Area of Science:

  • Cellular Biology
  • Ophthalmology
  • Neuroscience

Background:

  • Autophagy is a key cellular process for degrading damaged components.
  • Dysfunctional autophagy is linked to neurodegenerative diseases.
  • Diabetic retinopathy (DR) involves retinal neurodegeneration and inflammation beyond microvascular damage.

Purpose of the Study:

  • To review the role of autophagy in experimental models of diabetic retinopathy (DR).
  • To explore autophagy as a potential therapeutic target for DR.

Main Methods:

  • Literature review of experimental models of DR.
  • Analysis of studies investigating autophagy in the context of DR pathogenesis.

Main Results:

  • Evidence suggests autophagy plays a significant role in DR.
  • Autophagy modulation impacts retinal neurodegeneration in DR models.

Conclusions:

  • Autophagy is implicated in the neurodegenerative aspects of DR.
  • Targeting autophagy presents a promising avenue for novel DR therapies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
618
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.3K